Publications by authors named "Samit Ghosal"

Claim this Profile
O
Optimising GLP-1RA Efficacy: A Meta-Analysis of Baseline Age and HbA1c as Predictors of MACE Reduction in T2DM.
Samit Ghosal, Anuradha Ghosal

Diabetes Metab Syndr Obes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysis.
Binayak Sinha, Samit Ghosal

Addict Sci Clin Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA.
Binayak Sinha, Samit Ghosal

Obesity (Silver Spring)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Benefit Trade-offs of GLP-1RAs and SGLT-2is in Type 2 Diabetes Mellitus (T2D): Systematic Review, Meta-Analysis, and Net Benefit Modeling.
Samit Ghosal, Anuradha Ghosal

Diabetes Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India.
Debasis Datta, Krishna G Seshadri, Samit Ghosal

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational study.
Ajay Kumar, Anirban Mazumdar, A K Bhattacharjee, Arvind Gupta, Arundhati Dasgupta, Samit Ghosal

BMC Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial.
Awadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, Samit Ghosal, Rakesh Sahay

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient Program.
Bipin Sethi, Krishna Seshadri, Vaishali Deshmukh, Unnikrishnan Ag, Manash Baruah, Samit Ghosal

Cureus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study.
Binayak Sinha, Samit Ghosal

Diabetes Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled Trials.
Samit Ghosal, Shamita Ghosal, Anuradha Ghosal

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring.
Samit Ghosal, Binayak Sinha

Front Endocrinol (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight.
Samit Ghosal, Binayak Sinha, Rik Mukherjee

ESC Heart Fail· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis.
Samit Ghosal, Binayak Sinha

Diabetes Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysis.
Samit Ghosal, Binayak Sinha

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needs.
Shashank R Joshi, Rajesh Rajput, Subhankar Chowdhury, Awadhesh K Singh, Ganapathi Bantwal, Samit Ghosal

Diabetes Metab Syndr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome.
Binayak Sinha, Samit Ghosal

Front Endocrinol (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysis.
Samit Ghosal, Binayak Sinha

Diabetes Res Clin Pract· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D).
Samit Ghosal, Debasis Datta, Binayak Sinha

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials.
Binayak Sinha, Samit Ghosal

Diabetes Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting.
Samit Ghosal, Binayak Sinha, Jignesh Ved, Mansij Biswas

Indian Heart J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes.
Binayak Sinha, Debasis Datta, Samit Ghosal

JGH Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis.
Samit Ghosal, Bhavya Arora, Koel Dutta, Amerta Ghosh, Binayak Sinha

Diabetes Metab Syndr· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey".
Kalyan Kumar Gangopadhyay, Binayak Sinha, Samit Ghosal

Diabetes Metab Syndr· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials.
Binayak Sinha, Samit Ghosal

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis.
Samit Ghosal, Rahul Bhattacharyya, Milan Majumder

Diabetes Metab Syndr· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis